Regional Radiochemotherapy Using In Situ Hydrogel

[1]  F. Buchegger,et al.  131I-rituximab: relationship between immunoreactivity and specific activity. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  S. Kennel,et al.  Radiometals as payloads for radioimmunotherapy for lymphoma. , 2004, Clinical lymphoma.

[3]  S. Kennel,et al.  Radiometals as Payloads for Radioimmunotherapy for Lymphoma Lymphoma , 2004 .

[4]  M. Goris,et al.  Dosimetry model for radioactivity localized to intestinal mucosa. , 2004, Cancer biotherapy & radiopharmaceuticals.

[5]  Robert Gurny,et al.  Current methods for attaching targeting ligands to liposomes and nanoparticles. , 2004, Journal of pharmaceutical sciences.

[6]  T. Luo,et al.  Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection. , 2004, Nuclear medicine and biology.

[7]  William C Eckelman,et al.  Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin , 2004, Clinical Cancer Research.

[8]  S. Dharap,et al.  Molecular targeting of drug delivery systems to cancer. , 2004, Current drug targets.

[9]  Mark B. Jones,et al.  Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells* , 2004, Journal of Biological Chemistry.

[10]  J. Blanchette,et al.  Principles of Transmucosal Delivery of Therapeutic Agents , 2004 .

[11]  N. Iznaga-Escobar,et al.  188Re-labeled anti-epidermal growth factor receptor humanized monoclonal antibody h-R3: labeling conditions, in vitro and in vivo stability. , 2003, Methods and findings in experimental and clinical pharmacology.

[12]  Y. Tabata,et al.  In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[13]  M. Tian,et al.  Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. , 2003, Cancer biotherapy & radiopharmaceuticals.

[14]  R. Mehvar.  Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives. , 2003, Current pharmaceutical biotechnology.

[15]  A. Casadevall,et al.  Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Silber,et al.  Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions , 2003, Circulation.

[17]  N. Shuke,et al.  Feasibility of 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer , 2003, Journal of Cancer Research and Clinical Oncology.

[18]  D. Podoloff,et al.  Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia. , 2003, Cancer biotherapy & radiopharmaceuticals.

[19]  David J. Yang,et al.  Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. , 2003, Radiology.

[20]  M. A. Majali,et al.  A novel approach for the adsorption of iodine-125 on silver wire as matrix for brachytherapy source for the treatment of eye and prostate cancer. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[21]  G. Prestwich,et al.  Cancer-targeted polymeric drugs. , 2002, Current cancer drug targets.

[22]  R. Wahl,et al.  Choosing an optimal radioimmunotherapy dose for clinical response , 2002, Cancer.

[23]  A. Schubiger,et al.  Copper-67 as a therapeutic nuclide for radioimmunotherapy , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  H. Tønnesen,et al.  Alginate in Drug Delivery Systems , 2002, Drug development and industrial pharmacy.

[25]  X. Qu,et al.  Encapsulation of isotope on novel beta-emitting poly(ethylene terephthalate) surfaces. , 2001, Journal of biomedical materials research.

[26]  D. Mooney,et al.  Hydrogels for combination delivery of antineoplastic agents. , 2001, Biomaterials.

[27]  E. Krenning,et al.  [177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients , 2001, European Journal of Nuclear Medicine.

[28]  H. Döhner,et al.  Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation , 2001, European Journal of Nuclear Medicine.

[29]  J. Erion,et al.  Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆ , 2001 .

[30]  Y. Tabata,et al.  Controlled Release of Hepatocyte Growth Factor from Gelatin Hydrogels Based on Hydrogel Degradation , 2001, Journal of drug targeting.

[31]  F. Buchegger,et al.  Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  M. Watanabe,et al.  [In vitro analysis for cellular toxicity of polychlorinated biphenys (PCBs) on HeLa cellular proliferation (IV)--the effect of Kanpo preparations on cellular toxicity]. , 1997, Fukuoka igaku zasshi = Hukuoka acta medica.

[33]  Nath.  New Directions in Radionuclide Sources for Brachytherapy. , 1993, Seminars in radiation oncology.

[34]  T. Bandurski,et al.  Application of rhenium-188 HEDP in bone metastases therapy. , 2003, Nuclear medicine review. Central & Eastern Europe.

[35]  David J. Yang,et al.  Imaging with 99 mTc ECDG Targeted at the Multifunctional Glucose Transport System : Feasibility Study with Rodents 1 , 2003 .

[36]  N. Bander,et al.  In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen , 2002, Prostate Cancer and Prostatic Diseases.

[37]  B. Marples,et al.  Molecular approaches to chemo-radiotherapy. , 2002, European journal of cancer.

[38]  R. Pestell,et al.  Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). , 2002, Nuclear medicine and biology.

[39]  X. Qu,et al.  Deposition of (90)YPO(4) and (144)CePO(4) radioisotopes on polymer surfaces for radiation delivery devices. , 2002, Journal of biomedical materials research.

[40]  S. Reske,et al.  Endovascular irradiation with the liquid beta-emitter Rhenium-188 to reduce restenosis after experimental wall injury. , 2001, Cardiovascular research.

[41]  E P Krenning,et al.  [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients. , 2001, European journal of nuclear medicine.

[42]  G. T. Krishnamurthy,et al.  Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.